Fischer Medical Ventures Ltd
Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]
- Market Cap ₹ 3,825 Cr.
- Current Price ₹ 715
- High / Low ₹ 793 / 263
- Stock P/E 2,079
- Book Value ₹ 15.2
- Dividend Yield 0.00 %
- ROCE 5.25 %
- ROE 4.55 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 46.9 times its book value
- Company has high debtors of 398 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | |
|---|---|---|
| 0.18 | 20.98 | |
| 0.16 | 19.12 | |
| Operating Profit | 0.02 | 1.86 |
| OPM % | 11.11% | 8.87% |
| 0.00 | 0.50 | |
| Interest | 0.02 | 0.07 |
| Depreciation | 0.00 | 0.18 |
| Profit before tax | 0.00 | 2.11 |
| Tax % | 12.80% | |
| -0.04 | 1.84 | |
| EPS in Rs | -2.33 | 0.34 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 11556% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 4700% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 74% |
| 5 Years: | 66% |
| 3 Years: | 90% |
| 1 Year: | 176% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|
| Equity Capital | 0.17 | 53.50 | 53.50 |
| Reserves | -0.44 | 27.61 | 27.95 |
| 0.57 | 1.68 | 1.47 | |
| 0.05 | 3.53 | 57.80 | |
| Total Liabilities | 0.35 | 86.32 | 140.72 |
| 0.00 | 14.71 | 14.87 | |
| CWIP | 0.00 | 0.00 | 2.89 |
| Investments | 0.00 | 1.21 | 11.70 |
| 0.35 | 70.40 | 111.26 | |
| Total Assets | 0.35 | 86.32 | 140.72 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | |
|---|---|---|
| -7.59 | ||
| -28.61 | ||
| 37.11 | ||
| Net Cash Flow | 0.91 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | |
|---|---|---|
| Debtor Days | 344.72 | 397.88 |
| Inventory Days | ||
| Days Payable | ||
| Cash Conversion Cycle | 344.72 | 397.88 |
| Working Capital Days | 324.44 | 505.40 |
| ROCE % | 5.25% |
Documents
Announcements
-
Intimation Of License To Manufacture MRI By CDSCO To The Material Subsidiary Of The Company
23h - First indigenous MRI manufacturer in India receives CDSCO license.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
1d - Fischer Medical ventures Limited (formerly known as Fischer Chemic Limited) has informed on the Certificate under Regulation 74(5) of SEBI DP Regulations 2018
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
10 Jan - Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) informed on newspaper publication relating to notice of Extra ordinary General Meeting
-
Shareholders Meeting - EGM On 31/01/2025
9 Jan - Intimation of 1st Extra Ordinary General Meeting for FY 2024-2025.
-
Announcement under Regulation 30 (LODR)-Meeting Updates
3 Jan - Withdrawal of preferential issue and new share issuance.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Dec 2024TranscriptNotesPPT
Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals